SENTRY BIOPHARMA SERVICES
LIVE

Serial Number

79312619

Owner

Sentry BioPharrna Services, Inc.

Attorney

Kiranjit K Dharsan

Filing Date

Dec 1, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SENTRY BIOPHARMA SERVICES Trademark

Serial Number: 79312619 • Registration: 7301311

SENTRY BIOPHARMA SERVICES is a trademark filed by Sentry BioPharrna Services, Inc. on December 1, 2020. The trademark is classified under Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Sentry BioPharrna Services, Inc.

4605 Decatur Blvd

Entity Type: 03

Trademark Details

Filing Date

December 1, 2020

Registration Date

February 13, 2024

Published for Opposition

November 28, 2023

Goods & Services

Providing a web hosting platform for supply chain logistics and freight forwarding services; providing transportation information; electronic data storage services; computer services, namely, updating of computer programs

Providing business and statistical information and data processing services in the pharmaceutical, biotechnology, medical device, and diagnostics industries; compilation, updating and maintenance of information into computer databases; government relations consultancy services regarding customs clearance for third parties; business administration services, namely, customs clearance services for third parties

Advice and regulatory compliance consulting in the field of pharmaceuticals, biopharmaceuticals, medical devices, and diagnostics

Supply chain logistics and storage of temperature sensitive healthcare products for the pharmaceutical, biotechnology and medical device industries in a climate-controlled environment

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 26, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 26, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 26, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 26, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 26, 2026 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 2, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 14, 2024 FICS
FINAL DISPOSITION PROCESSED
May 14, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 13, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 28, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Nov 27, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 8, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 8, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2023 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 16, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 26, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 26, 2023 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 5, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 1, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 1, 2022 GNSL
SUSPENSION LETTER WRITTEN
Sep 1, 2022 CNSL
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 10, 2022 CORN
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 4, 2022 TROA
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 28, 2021 CRCV
REFUSAL PROCESSED BY IB
Aug 29, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 6, 2021 RFCS
REFUSAL PROCESSED BY MPU
Aug 5, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 28, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jul 27, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 12, 2021 MAFR
ASSIGNED TO EXAMINER
Jun 8, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 3, 2021 REPR